NHSA
Government Program · Beijing, China
43reach
OncologyRare diseaseCell & gene therapyImmunology
Value-basedSpecialtyNRDL (China)NMPAHTA
FORM 75REIMB 792 locations
Loading…
Market Access & Reimbursement
Payers
Coverage, formulary & market access9
payers listed
Health plans, coverage, formulary and market-access partners — the reimbursement path your launch depends on.
Scores are deterministic, rules-based — not AI.
MarketplacesPayers
9 payers
Sort
OncologyImmunologyCardiometabolicRare disease
Value-basedSpecialtyNRDL (China)NMPAHTA
FORM 66REIMB 792 locations
OncologyCardiometabolicRare diseasePrimary care
SpecialtyNHI (Japan)NMPAHTA
FORM 66REIMB 792 locations
OncologyCardiometabolicRare diseaseImmunology
Value-basedSpecialtyNHI (Japan)NMPAHTA
FORM 66REIMB 791 locations
OncologyCardiometabolicImmunologyRare disease
Value-basedSpecialtyNRDL (China)NMPA
FORM 66REIMB 791 locations
CardiometabolicOncologyPrimary careSpecialty
SpecialtyNRDL (China)NMPA
FORM 43REIMB 791 locations
Primary careCardiometabolicInfectious diseaseOncology
SpecialtyNRDL (China)NMPA
FORM 43REIMB 721 locations
Primary careCardiometabolicOncology
SpecialtyNHI (Japan)NMPA
FORM 43REIMB 721 locations
Primary careCardiometabolic
NHI (Japan)NMPA
FORM 18REIMB 721 locations